Global footprint Vitalis operates in 20 countries across Latin America and Asia with 7 GMP-certified production plants, indicating a broad regional reach and potential for cross-border supply partnerships, contract manufacturing, or regional distribution agreements.

Injectable focus As a specialist in injectable medicines with multiple facilities, there is a potential to offer sterile production services, fill-finish capabilities, or development partnerships for complex dosage forms to pharma and biotech customers seeking reliable aseptic manufacturing.

Safety leadership Recognition for patient safety through safe drug identification strategies positions Vitalis as a quality-focused partner; leverage this for risk-sharing manufacturing contracts, serialization/compliance consulting, or audits for large buyers prioritizing safety and traceability.

GMP certification Seven GMP-certified plants in Colombia, Mexico, and Chile suggest capacity and regional compliance strength; target regional pharma players and distributors needing validated manufacturing capacity and GMP-backed supply continuity.

Strategic partnerships Internationally recognized status plus a multinational workforce imply potential for channel partnerships, co-development deals, and supplier relationships with health systems or governments seeking dependable manufacturers with global standards.